688488 艾迪藥業
按盤價 
9.370 +1.470 (+18.608%) | 2024/06 - 中期 人民幣(K¥) | 與去年末期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 100,085 | 8.95% | 91,865 | 90,584 | 8,199 | 1,943 |
| 投資性房地產 | 0 | -- | 0 | 0 | 0 | 0 |
| 固定資產 | 420,207 | -2.98% | 433,130 | 407,058 | 227,060 | 238,743 |
| 在建工程 | 490 | -84.30% | 3,121 | 36,815 | 95,229 | 17,210 |
| 無形資產 | 108,978 | -4.90% | 114,591 | 117,622 | 128,230 | 54,363 |
| 商譽 | 13,239 | 0.00% | 13,239 | 13,239 | 13,239 | 13,239 |
| 其他非流動資產 | 228,958 | 4.91% | 218,237 | 187,776 | 135,726 | 114,605 |
| 871,957 | -0.25% | 874,184 | 853,094 | 607,684 | 440,103 | |
流動資產 | ||||||
| 貨幣資金 | 216,580 | -3.89% | 225,356 | 134,908 | 442,706 | 244,684 |
| 應收賬款 | 203,340 | 11.47% | 182,416 | 113,829 | 58,259 | 121,694 |
| 存貨 | 210,988 | 14.12% | 184,878 | 156,151 | 114,269 | 88,061 |
| 其他流動資產 | 165,673 | -40.77% | 279,731 | 397,568 | 211,697 | 552,285 |
| 796,582 | -8.69% | 872,381 | 802,456 | 826,931 | 1,006,724 | |
流動負債 | ||||||
| 短期借款 | 215,497 | -15.67% | 255,553 | 145,155 | 0 | 0 |
| 應付票據 | 22,042 | 594.24% | 3,175 | 10,310 | 15,880 | 14,435 |
| 應付帳款 | 76,933 | -30.31% | 110,391 | 109,130 | 48,977 | 25,301 |
| 其他流動負債 | 202,089 | 65.04% | 122,448 | 67,079 | 27,685 | 33,267 |
| 516,560 | 5.08% | 491,568 | 331,675 | 92,542 | 73,003 | |
| 流動資產淨值 | 280,022 | -26.47% | 380,813 | 470,780 | 734,389 | 933,721 |
| 資產總額減流動負債 | 1,151,979 | -8.21% | 1,254,997 | 1,323,874 | 1,342,072 | 1,373,824 |
非流動負債 | ||||||
| 長期借款 | 9,890 | -85.86% | 69,940 | 60,000 | 0 | 0 |
| 應付債券 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動負債 | 58,234 | -2.16% | 59,519 | 64,891 | 32,275 | 13,967 |
| 68,124 | -47.38% | 129,459 | 124,891 | 32,275 | 13,967 | |
總權益 | ||||||
| 實收股本 | 420,783 | 0.00% | 420,783 | 420,000 | 420,000 | 420,000 |
| 儲備項目 | 663,072 | -5.91% | 704,755 | 778,983 | 889,797 | 939,857 |
| 股東權益 | 1,083,855 | -3.70% | 1,125,538 | 1,198,983 | 1,309,797 | 1,359,857 |
| 非控股權益 | 0 | -- | 0 | 0 | 0 | 0 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
